RespireRx Pharmaceuticals Inc (RSPI)

[neuroinv]

Two other notes:
1) It will be interesting to see which of the current directors is retained.
2) Arnold Lippa was a founder and CEO of Dov Pharmaceuticals. They were a highflier for a while on the basis of their indiplon partnership with Neurocrine Biosciences, subsequently licensed to Pfizer. When indiplon ran into FDA problems, Pfizer departed, Neurocrine languished until reviving itself outside of CNS, and Dov was liquidated, its remaining assets picked up for a pittance by Euthymics Bioscience, with funding from Novartis Bioventure. They are in Phase IIb for depression, and spun out Neurovance, in Phase IIa for ADHD.


NP